Investigating how a genetic variant affects survival during pneumococcal sepsis
Novel coenzyme Q6 variant reveals non-immune determinants of survival during pneumococcal sepsis
This study is looking at how a certain gene might affect how well people with pneumococcal sepsis survive, using a special mouse model to understand the immune system's role, with the hope of finding better treatments for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10945803 on NIH RePORTER |
What this research studies
This research explores the role of a specific genetic variant in coenzyme Q6 that may influence survival rates in patients suffering from pneumococcal sepsis. The study utilizes a novel mouse model to differentiate between immune and non-immune factors affecting mortality during sepsis. By analyzing how this genetic variant impacts the body's response to infection, the research aims to uncover new insights that could lead to improved treatment strategies for sepsis patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced pneumococcal sepsis or are at high risk for developing this condition.
Not a fit: Patients who do not have a history of pneumococcal infections or sepsis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic approaches that enhance survival rates for patients with pneumococcal sepsis.
How similar studies have performed: While the immune-centric model of sepsis has been widely studied, this research introduces a novel perspective by focusing on non-immune factors, making it a potentially groundbreaking approach.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Morley, Sharon Celeste — Washington University
- Study coordinator: Morley, Sharon Celeste
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.